Commercial success is the ultimate goal after clinical development. GCI’s Commercialization Services ensure that your therapies are successfully launched, adopted, and sustained in the market. We bridge the gap between clinical research and market access by combining real-world evidence, stakeholder engagement, and strategic insights.
Service features
Our commercialization solutions help sponsors maximize product value, accelerate market uptake, and achieve long-term growth through tailored launch planning, pricing strategies, and post-market lifecycle management.
Market Access & Reimbursement Strategy
Development of pricing, reimbursement, and payer negotiation strategies.
Stakeholder & KOL Engagement
Building strong relationships with healthcare providers, policymakers, and patient advocacy groups.
Launch Excellence
Strategic planning and execution for impactful product launches.
Lifecycle Management
Post-launch monitoring, evidence generation for label expansion, and market sustainability.
Problems we solve
- Limited payer acceptance due to lack of economic evidence
- Slow market uptake post-approval
- Misaligned pricing and reimbursement strategies
Popular questions
How early should commercialization planning start?
Ideally, during the late stages of clinical development (Phase III) to align trial data with payer and market needs.
Does GCI handle both pre-launch and post-launch activities?
Yes, GCI provides end-to-end commercialization support, including strategy development, launch planning, and lifecycle management.
Can GCI assist in market expansion beyond Australia?
Absolutely. Our commercialization expertise spans APAC, Europe, and North America.
